Crude Heparin Market

Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.
Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines.
Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of Crude Heparin Market is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Crude Heparin Market contains market size and forecasts of Crude Heparin in global, including the following market information:
Global Crude Heparin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Crude Heparin Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Crude Heparin companies in 2021 (%)
The global Crude Heparin market was valued at 3855.8 million in 2021 and is projected to reach US$ 7722.5 million by 2028, at a CAGR of 10.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pig Intestine Mucosa Heparin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Crude Heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong and Hepac (Darling Ingredients), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Crude Heparin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Crude Heparin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Crude Heparin Market Segment Percentages, by Type, 2021 (%)
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Global Crude Heparin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Crude Heparin Market Segment Percentages, by Application, 2021 (%)
Unfractionated Heparin (UFH)
Low-Molecular-Weight Heparin (LMWH)
Global Crude Heparin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Crude Heparin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Crude Heparin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Crude Heparin revenues share in global market, 2021 (%)
Key companies Crude Heparin sales in global market, 2017-2022 (Estimated), (MT)
Key companies Crude Heparin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals